Microneedle-enabled therapeutics delivery and biosensing in clinical trials

J Control Release. 2023 Aug:360:687-704. doi: 10.1016/j.jconrel.2023.07.023. Epub 2023 Jul 19.

Abstract

Microneedles (MNs) are micron-sized protrusions attached to a range of devices that are used in therapeutic delivery and diagnosis. Because MNs can be self-applied, are painless, and can carry multiple therapeutic agents, they have received extensive attention, and have been widely investigated, for local and systemic therapy. Many researchers are currently working to extend the use of MNs to clinical applications. In this review, we provide an update and analysis on MN-based clinical trials since their inception in 2007. The MNs in clinical trials are classified into five types based on their appearance and properties, including: hollow MNs, MN patches, radiofrequency MNs, MN rollers, and other MNs. The various aspects of MN trials are summarized, such as MN types, clinical trial time, and trial regions. This review aims to present an overview of MN development and provide insights for future research in this field. To our knowledge, this is the first review focused on MN clinical trials which showcases the latest applications of this advanced technology in medicine.

Keywords: Clinical trial; Diagnosis; Drug delivery; Microneedle; New therapy; Polymer.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Drug Delivery Systems*
  • Microinjections
  • Needles
  • Skin*